Related Experiment Video
Updated: Aug 11, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Tuberculosis revisited or how we nearly conquered tuberculosis
1University of Edinburgh.
Post-WWII tuberculosis treatment saw major advances with new drugs like streptomycin. However, inconsistent global adoption of effective regimens led to widespread drug resistance and a worsening worldwide TB epidemic.
Area of Science:
- Medicine
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) posed a significant threat, particularly during Scotland's post-WWII epidemic.
- The advent of streptomycin, PAS, and isoniazid revolutionized TB treatment, making it highly curable.
Purpose of the Study:
- To highlight the successful Edinburgh regimen for treating tuberculosis.
- To analyze the reasons for the slow global adoption of effective TB treatment strategies.
- To underscore the negative consequences of suboptimal TB management worldwide.
Main Methods:
- Recounting clinical experience as a chest physician in the post-war era.
- Observing the outcomes of a comprehensive multi-drug TB treatment policy.
- Analyzing global trends in TB incidence and drug resistance.
Main Results:
- The Edinburgh team achieved high cure rates with minimal drug resistance using streptomycin, PAS, and isoniazid routinely.
- Slow and inconsistent adoption of this effective policy globally led to treatment failures.
- Worldwide TB incidence has increased, particularly in developing nations, due to treatment challenges.
Conclusions:
- The early, widespread adoption of effective multi-drug TB therapy was crucial for controlling the disease.
- Failure to implement optimal treatment regimens globally has resulted in a resurgence of TB and drug resistance.
- Lessons learned from the post-war era emphasize the need for standardized, evidence-based TB treatment protocols worldwide.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis